Bone and soft tissue changes in paraplegic patients.

Bone and Soft Tissue Changes after Two-Jaw Surgery in Cleft Patients.

Bone and soft tissue ablation.

Soft tissue reactions in patients with bone anchored hearing aids.

Longitudinal study of calcium and bone metabolism in paraplegic patients.

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group.

Immunotherapy for Bone and Soft Tissue Sarcomas.

Changes in treating soft-tissue sarcomas.

Bone resorption, stability, and soft-tissue changes following large chin advancements.

Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.

Bone and soft tissue injuries in post-mortem lumbar spines.

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center.

Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective.

Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.

Radiation-associated sarcoma of bone and soft tissue.

Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.

Soft tissue calcification in chronic dialysis patients.

Age changes of jaws and soft tissue profile.

Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas.

Changes in the soft tissue chin after orthodontic treatment.

Growth changes in the soft tissue facial profile.

The histopathology of different foreign-body reactions in oral soft tissue and bone tissue.

Evaluation of long-term soft tissue changes after bimaxillary orthognathic surgery in Class III patients.

soft tissue interface.

Ossified soft tissue recurrence of giant cell tumor of bone.

Suggest Documents

Bone and Soft Tissue Changes after Two-Jaw Surgery in Cleft Patients.

Bone and soft tissue ablation.

Soft tissue reactions in patients with bone anchored hearing aids.

Longitudinal study of calcium and bone metabolism in paraplegic patients.

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group.

Immunotherapy for Bone and Soft Tissue Sarcomas.

Changes in treating soft-tissue sarcomas.

Bone resorption, stability, and soft-tissue changes following large chin advancements.

Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.

Bone and soft tissue injuries in post-mortem lumbar spines.

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center.

Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective.

Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.

Radiation-associated sarcoma of bone and soft tissue.

Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.

Soft tissue calcification in chronic dialysis patients.

Age changes of jaws and soft tissue profile.

Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas.

Changes in the soft tissue chin after orthodontic treatment.

Growth changes in the soft tissue facial profile.

The histopathology of different foreign-body reactions in oral soft tissue and bone tissue.

Evaluation of long-term soft tissue changes after bimaxillary orthognathic surgery in Class III patients.

soft tissue interface.

Ossified soft tissue recurrence of giant cell tumor of bone.

Bone and soft tissue changes in paraplegic patients.

Recommend Documents

Follow Us